SBI Life Q1 Review - Steady Growth Amid Lockdown; Covid-19 Claims Elevated: ICICI Direct

An applicant fills out an application form. (Photographer: Shiho Fukada/Bloomberg)

SBI Life Q1 Review - Steady Growth Amid Lockdown; Covid-19 Claims Elevated: ICICI Direct

Bookmark

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

SBI Life Insurance Company Ltd.'s premium growth remained moderate at 10% YoY to Rs 8,313 crore, led by 9.4% YoY traction in new business premium of Rs 3,345 crore.

Growth in renewal premium continued to remain healthy at ~9.8% YoY to Rs 5032 crore, with improvement in 13th month persistency at 84.5%.

In terms of NBP breakup, traction in individual business witnessed healthy pick up at 33% YoY to Rs 1,840 crore, primarily led by ~59% YoY rise in unit linked business.

SBI Life's protection business (individual plus group) continued to report strong growth at Rs 430 crore versus Rs 290 crore YoY.

Proportion of total protection NBP to total NBP was at ~13% in Q1 FY22 versus 9.5% in Q1 FY21.

Click on the attachment to read the full report:

ICICI Direct SBI Life Q1FY22 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.